Cereset Research Standard Operating Procedures for Insomnia: A Randomized, Controlled Clinical Trial

Area of Science:

• Neuroscience
• Sleep Medicine
• Autonomic Function Research

Background:

• Insomnia often co-occurs with autonomic dysfunction, necessitating integrated treatment approaches.
• Acoustic stimulation neurotechnology has shown promise for improving both insomnia and autonomic function.

Purpose of the Study:

• To evaluate the efficacy of Cereset Research™ Standard Operating Procedures (CR-SOP), an innovation of HIRREM®, in a pilot randomized controlled trial.
• To assess CR-SOP's impact on insomnia severity, sleep quality, and autonomic function.

Main Methods:

• Adults with insomnia (Insomnia Severity Index score ≥8) were randomized to CR-SOP (brainwave-linked tones) or a sham control (random tones).
• Primary outcome was change in Insomnia Severity Index (ISI) from baseline to 4-6 weeks post-intervention.
• Secondary outcomes included sleep quality, behavioral measures, heart rate variability (HRV), and baroreflex sensitivity.

Main Results:

• The intervention group showed a clinically relevant reduction in insomnia severity, comparable to a previous trial.
• Significant improvements in sleep quality and some autonomic function measures (HRV, baroreflex sensitivity) were observed in the CR-SOP group compared to the sham control.
• While the intervention group had a greater reduction in ISI score, the difference between groups was not statistically significant (P = .24).

Conclusions:

• CR-SOP, a standardized acoustic neurotechnology, demonstrated potential benefits for insomnia and associated autonomic dysfunction.
• The study suggests CR-SOP may be a viable non-pharmacological intervention for improving sleep and autonomic regulation.
• Further research with larger sample sizes is warranted to confirm statistical significance and clinical utility.